Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Expanded_access × Vaccination × Clear all

Status

Sponsor Class

Study Type

Interventional 7 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

3-Iodobenzylguanidine 6 Magnetic Resonance Spectroscopy 5 gallium 68 PSMA-11 4 Amifampridine 4 fludarabine phosphate 3 Cyclophosphamide 3 pembrolizumab 2 fludarabine 2 carbon-11 acetate 2 Bone Marrow Transplantation 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 veliparib 1 selinexor 1 pegfilgrastim 1 omburtamab I-131 1 nirogacestat 1 motexafin gadolinium 1 mifamurtide 1 glucarpidase 1 ganitumab 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 fluorocholine 1 epigallocatechin gallate 1 elotuzumab 1 carfilzomib 1 carbon-11 methionine 1 asparaginase erwinia chrysanthemi recombinant 1 aldesleukin 1 Whole-Body Irradiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05356312 2024-03-01

Glioblastoma and Individualized Therapies

Zentrum fur Humangenetik Tuebingen

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡